Aashka Hospitals

SMEBSE: 543346
Compare with peers
₹ 97.95▼ 7.05 (−6.71%)28 Oct, 02:41 pm IST
P/E
83.7x
52-week range
59 – 108
ROE
3%
ROCE
4.1%
Sector
Healthcare Services
Industry
Hospital
Listed on
BSE SME

About

Aashka Hospitals Limited is an India-based company. Its principal activities include the operation of multi-disciplinary private hospitals, clinics, and pharmacies. The main business is to provide comprehensive hospital services. It operates under Anesthesiology, Cardiology, Cardiothoracic & Vascular Surgery, Critical Care, Dentistry, Dermatology & Cosmetology, ENT, Emergency and Trauma Care, Endoscopy, Gastroenterology & Gastroentero Surgery, General and Laparoscopic Surgery, Interventional Radiology, Internal Medicine Including Geriatrics, Medical Oncology/Haemato Oncology, Nephrology and Dialysis, Neurology, Neurosurgery, Obstetrics & Gynecology, Orthopedics and Joint Replacement, Ophthalmology, Physiotherapy and Rehabilitation, Plastic and Reconstructive Surgery, Pediatrics & Neonatology, Psychiatry, Pain Management, Pulmonology, Radiology, Surgical Oncology, Urology, Pathology, Medical Gastroenterology, including Hepatology, Infectious Diseases, and Diabetology and Endocrinology.

Quick check

The five things to look at first. Open one for more.

Compared with its industry

Hospital: 41 companies →

Aashka Hospitals against the typical company in its industry. The rank is out of the companies that report each figure; green means the better quarter of the pack, red the worse quarter.

  • Valuation (P/E)83.7 against a typical 48.9: pricier than most peers (1st = cheapest).27th of 40
  • Sales growth+4.1% against a typical +21.1% from a year earlier.29th of 34
  • Profit growth+32.6% against a typical +13% from a year earlier.12th of 31
  • Share price, 3 months+31.9% against a typical −10.9%.3rd of 34

Share price

1Y change +9.81%
Volume (shares)Price (₹)
Close price

Financials

Standalone figures in ₹ crore.

Quarterly results
₹ Cr.Mar 2021Sep 2021Mar 2022Sep 2022Mar 2023Sep 2023Mar 2024Sep 2024Mar 2025Sep 2025Mar 2026
Sales252811127111212101013
Expenses19191211810881089
Operating Profit59−11−1144−023
OPM %21.8%31.7%−6.5%6.4%−6.8%7.7%30.1%36.2%−2%20.2%24.9%
Other Income00003320412
Interest111−03111111
Depreciation11111112112
Profit before tax36−3−0−2122213
Tax %0%0%0%0%0%17.7%17.1%16.5%14.6%15.2%15.5%
Net Profit36−3−0−2022213
EPS in Rs1.432.64−1.42−0.2−0.90.180.820.690.710.331.09

Growth and returns

Compounded yearly rates over each period.

Compounded Sales Growth
10 Years
—
5 Years
−11%
3 Years
7%
TTM
2%
Compounded Profit Growth
10 Years
—
5 Years
−7%
3 Years
46%
TTM
21%
Stock Price CAGR
10 Years
—
5 Years
16%
3 Years
18%
TTM
—
Return on Equity
10 Years
—
5 Years
2%
3 Years
3%
TTM
—

Shareholding

Latest: Mar 2026.

Promoters
61.34%
+0.06 pts in a year
Public
38.67%
−0.04 pts in a year

P/E and EPS over time

Daily P/E and trailing 12-month EPS. EPS updates with each result.

P/E 83.7xEPS (12 months) ₹ 1.17Median P/E 65.9x
P/E (times)EPS (₹)

Peers

Listed companies in the same business.

Peer comparison
Aashka Hospitals₹ 97.95—83.7x—3%—
Apollo Hospitals Enterprise₹ 7,731.95₹ 1,11,174 Cr.63.8x13.2x—8.1%
Max Healthcare Institute₹ 817.00₹ 79,519 Cr.65x9x—16.7%
Fortis Healthcare₹ 720.00₹ 54,357 Cr.65.5x7x—11.3%
Aster DM Healthcare₹ 651.00₹ 56,817 Cr.93.9x8.5x—7.4%
Narayana Hrudayalaya₹ 1,667.25₹ 33,862 Cr.44x8.3x—9.1%

Prices are delayed and for information only. Nothing on this page is investment advice.